(a) The treatment schedules for mouse experiments are shown. (b d) Blood glucose levels were measured after intraperotoneal injection of 2 g kg−1 glucose in pregnant mice (G13) fed a tryptophan-free (“Trp-free”, b), histidine-free (“His-free”, b) or low tryptophan (“Low Trp”, c) diet or treated with PCPA (300 mg kg−1 day−1)(c) or non-pregnant female mice (d) treated as shown. n = 5 18 mice per treatment group. (e) The Htr mRNAs shown were amplified by RT-PCR from mouse islet and brain RNA. (f) The mRNAs shown were amplified by RT-PCR from mouse islets, β-cells (GFP+), non-β islet cells (GFP−), brain, and β-cell lines MIN6 and βTC3. (g, h) mRNA levels for Htr2a and Htr2b (g) and Htr1b and Htr1d (h) measured by real time RT-PCR in islet RNA harvested at the gestational dates indicated are shown relative to the levels in islets from non-pregnant female mice. n = 3–6 mice per data point. (i) Blood glucose levels were measured after intraperitoneal injection of glucose (2 g kg−1)in pregnant mice treated with SB204741 (1 mg kg−1 day−1), Methysergide (3 mg kg−1 day−1) or Ketanserin (1 mg−1 kg−1 day−1). n = 5 18 mice per treatment group. (j) Pregnant mice were treated as in Fig. 2a with tryptophan-free diet, PCPA or SB204741 and fasted for 6 hours at G13 before measuring insulin in plasma collected before and 30 minutes after intraperitoneal injection of 2 g/kg glucose. n = 4 7 mice per group. All data are presented as mean ± standard error. Statistical significance vs. untreated control (b, c, i and j) or vs. non-pregnant control (g and h) was analyzed by Student’s t test: *, P < 0.05; **, P < 0.01; ***, P < 0.001.